Silvercrest Asset Management Group LLC Tela Bio, Inc. Transaction History

Silvercrest Asset Management Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.54 - $11.49 $2.2 Million - $4.56 Million	-396,585 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$11.35 - $13.7 $40,973 - $49,457	3,610 Added 0.92%	396,585 $4.61 Million
Q3 2021 Nov 15, 2021	SELL	$12.2 - $15.93 $109,690 - $143,226	-8,991 Reduced 2.24%	392,975 $5.37 Million
Q2 2021 Aug 16, 2021	BUY	$11.7 - $16.11 $1.87 Million - $2.57 Million	159,530 Added 65.8%	401,966 $6.48 Million
Q1 2021 May 17, 2021	SELL	$12.84 - $17.26 $383,993 - $516,177	-29,906 Reduced 10.98%	242,436 $3.61 Million
Q4 2020 Feb 16, 2021	SELL	$14.61 - $17.59 $679,511 - $818,110	-46,510 Reduced 14.59%	272,342 $4.1 Million
Q3 2020 Nov 16, 2020	SELL	$11.64 - $16.86 $71,562 - $103,655	-6,148 Reduced 1.89%	318,852 $5.27 Million
Q2 2020 Aug 14, 2020	BUY	$7.75 - $22.61 $2.52 Million - $7.35 Million	325,000 New	325,000 $4.21 Million

18.3M

759K

100

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $57.7M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.